SPECIAL NOTICE
99 -- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
- Notice Date
- 12/23/2021 9:57:02 AM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NIH National Cancer Institute Rockville MD 20850 USA
- ZIP Code
- 20850
- Response Due
- 1/3/2022 1:00:00 PM
- Description
- Description: �National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Notice: This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR). The FNLCR is a Government-Owned Contractor-Operated� Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with Government, university, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. �FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings. Responses submitted to this Special Notice are not offers and cannot be accepted by the Government to form a binding contract. It is the responsibility of the interested parties to monitor this site, and any sites referenced herein, for additional information pertaining to business opportunities with the FNLCR, if any. Title:� �� Chemical Biology Consortium within the NCI Experimental Therapeutics (NExT) Program Project Background and Objectives:������� A.���������� Background A.1.������ General The Chemical Biology Consortium within the NCI Experimental Therapeutics (NExT) Program (NExT �and CBC ) helps translate promising scientific discoveries into tomorrow�s anticancer therapeutics. Scientists at CBC institutions work on oncology-focused drug discovery projects. They engage in hit discovery through HTS, advance hits to leads, and optimize leads to identify potential IND candidates. Projects are accepted into the NExT Program following an external scientific evaluation process. CBC Members can be public or private institutions, large or small, academic or for-profit. What each CBC Member brings to the Consortium is knowledge and expertise in small molecule drug discovery, with highly skilled scientists and technical capabilities to advance projects from various drug discovery stages to the clinic. To learn more about the NExT CBC Program and the Solicitation process, two Pre-Solicitation teleconferences will be held prior to the release of the Solicitation in January 2022. The first teleconference is scheduled for January 4, 2022 at 11AM EST and the second teleconference is scheduled for January 5, 2022 at 2PM EST.� To receive an invite to the Pre-Solicitation teleconferences, please contact: Leidos Biomed Subcontracts Department at: cbcproposals@mail.nih.gov �� CBC Members participate in the Consortium through subcontracts with Leidos Biomed. To be considered, offerors must respond to the Solicitation to be issued by Leidos Biomed. For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/3a301106904343da85d198de001c5988/view)
- Record
- SN06204405-F 20211225/211223230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |